Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In the most recent trading session, Eli Lilly (LLY) closed at $822.27, indicating a -0.22% shift from the previous trading day.

Proficio Capital Partners LLC lifted its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 30.2% in the fourth ...

Eli Lilly stock jumped 5.46% to $263.0 in pre-market trading on Wednesday. It surged over 47% so far this year.

Eli Lilly (LLY) stock is higher Thursday after the pharmaceutical company beat profit expectations and matched revenue forecasts for its fourth quarter and issued a better-than-expected outlook ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Friday – BofA Securities maintained a Buy rating on Eli Lilly stock (NYSE:LLY), with a price target set at $997.00. With a ...

Obesity drugs, durable revenue bringing Big Money investors to Eli Lilly and Company (LLY).

The stock has climbed nearly 17% so far ... In its fourth-quarter, Eli Lilly results exceeded Wall Street forecasts and indicated a more than twofold rise in revenue from its weight loss and ...

Back in December, I argued why I was ready to upgrade the stock of the embattled weight loss drugs leader Eli ... forecast period. While it has the potential to gain market share against NVO ...

or is Lilly stock still a buy? Let's find out. Image source: Getty Images. What's behind Lilly's double-digit revenue growth So, first let's talk about the Eli Lilly story so far. It's important ...

Investing.com - Eli Lilly ... Investing.com -- US stock futures steadied Tuesday after the previous session’s losses, with trading ranges limited ahead of... Phase 3 results for Lilly's ...